Copyright Reports & Markets. All rights reserved.

Global Alzheimer’s Therapeutic Market Size, Status and Forecast 2019-2025

Request for Sample of this report
Buy now

Table of Contents

    1 Report Overview

    • 1.1 Study Scope
    • 1.2 Key Market Segments
    • 1.3 Players Covered
    • 1.4 Market Analysis by Type
      • 1.4.1 Global Alzheimer’s Therapeutic Market Size Growth Rate by Type (2014-2025)
      • 1.4.2 Memantine Hydrochloride
      • 1.4.3 Donepezil Hydrochloride
      • 1.4.4 Rivastigmine
      • 1.4.5 Galantamine Hydrobromide
    • 1.5 Market by Application
      • 1.5.1 Global Alzheimer’s Therapeutic Market Share by Application (2014-2025)
      • 1.5.2 Hospitals
      • 1.5.3 Clinic
      • 1.5.4 Other
    • 1.6 Study Objectives
    • 1.7 Years Considered

    2 Global Growth Trends

    • 2.1 Alzheimer’s Therapeutic Market Size
    • 2.2 Alzheimer’s Therapeutic Growth Trends by Regions
      • 2.2.1 Alzheimer’s Therapeutic Market Size by Regions (2014-2025)
      • 2.2.2 Alzheimer’s Therapeutic Market Share by Regions (2014-2019)
    • 2.3 Industry Trends
      • 2.3.1 Market Top Trends
      • 2.3.2 Market Drivers
      • 2.3.3 Market Opportunities

    3 Market Share by Key Players

    • 3.1 Alzheimer’s Therapeutic Market Size by Manufacturers
      • 3.1.1 Global Alzheimer’s Therapeutic Revenue by Manufacturers (2014-2019)
      • 3.1.2 Global Alzheimer’s Therapeutic Revenue Market Share by Manufacturers (2014-2019)
      • 3.1.3 Global Alzheimer’s Therapeutic Market Concentration Ratio (CR5 and HHI)
    • 3.2 Alzheimer’s Therapeutic Key Players Head office and Area Served
    • 3.3 Key Players Alzheimer’s Therapeutic Product/Solution/Service
    • 3.4 Date of Enter into Alzheimer’s Therapeutic Market
    • 3.5 Mergers & Acquisitions, Expansion Plans

    4 Breakdown Data by Type and Application

    • 4.1 Global Alzheimer’s Therapeutic Market Size by Type (2014-2019)
    • 4.2 Global Alzheimer’s Therapeutic Market Size by Application (2014-2019)

    5 United States

    • 5.1 United States Alzheimer’s Therapeutic Market Size (2014-2019)
    • 5.2 Alzheimer’s Therapeutic Key Players in United States
    • 5.3 United States Alzheimer’s Therapeutic Market Size by Type
    • 5.4 United States Alzheimer’s Therapeutic Market Size by Application

    6 Europe

    • 6.1 Europe Alzheimer’s Therapeutic Market Size (2014-2019)
    • 6.2 Alzheimer’s Therapeutic Key Players in Europe
    • 6.3 Europe Alzheimer’s Therapeutic Market Size by Type
    • 6.4 Europe Alzheimer’s Therapeutic Market Size by Application

    7 China

    • 7.1 China Alzheimer’s Therapeutic Market Size (2014-2019)
    • 7.2 Alzheimer’s Therapeutic Key Players in China
    • 7.3 China Alzheimer’s Therapeutic Market Size by Type
    • 7.4 China Alzheimer’s Therapeutic Market Size by Application

    8 Japan

    • 8.1 Japan Alzheimer’s Therapeutic Market Size (2014-2019)
    • 8.2 Alzheimer’s Therapeutic Key Players in Japan
    • 8.3 Japan Alzheimer’s Therapeutic Market Size by Type
    • 8.4 Japan Alzheimer’s Therapeutic Market Size by Application

    9 Southeast Asia

    • 9.1 Southeast Asia Alzheimer’s Therapeutic Market Size (2014-2019)
    • 9.2 Alzheimer’s Therapeutic Key Players in Southeast Asia
    • 9.3 Southeast Asia Alzheimer’s Therapeutic Market Size by Type
    • 9.4 Southeast Asia Alzheimer’s Therapeutic Market Size by Application

    10 India

    • 10.1 India Alzheimer’s Therapeutic Market Size (2014-2019)
    • 10.2 Alzheimer’s Therapeutic Key Players in India
    • 10.3 India Alzheimer’s Therapeutic Market Size by Type
    • 10.4 India Alzheimer’s Therapeutic Market Size by Application

    11 Central & South America

    • 11.1 Central & South America Alzheimer’s Therapeutic Market Size (2014-2019)
    • 11.2 Alzheimer’s Therapeutic Key Players in Central & South America
    • 11.3 Central & South America Alzheimer’s Therapeutic Market Size by Type
    • 11.4 Central & South America Alzheimer’s Therapeutic Market Size by Application

    12 International Players Profiles

    • 12.1 Pfizer
      • 12.1.1 Pfizer Company Details
      • 12.1.2 Company Description and Business Overview
      • 12.1.3 Alzheimer’s Therapeutic Introduction
      • 12.1.4 Pfizer Revenue in Alzheimer’s Therapeutic Business (2014-2019)
      • 12.1.5 Pfizer Recent Development
    • 12.2 Novartis
      • 12.2.1 Novartis Company Details
      • 12.2.2 Company Description and Business Overview
      • 12.2.3 Alzheimer’s Therapeutic Introduction
      • 12.2.4 Novartis Revenue in Alzheimer’s Therapeutic Business (2014-2019)
      • 12.2.5 Novartis Recent Development
    • 12.3 Axovant Sciences
      • 12.3.1 Axovant Sciences Company Details
      • 12.3.2 Company Description and Business Overview
      • 12.3.3 Alzheimer’s Therapeutic Introduction
      • 12.3.4 Axovant Sciences Revenue in Alzheimer’s Therapeutic Business (2014-2019)
      • 12.3.5 Axovant Sciences Recent Development
    • 12.4 Acadia Pharmaceuticals
      • 12.4.1 Acadia Pharmaceuticals Company Details
      • 12.4.2 Company Description and Business Overview
      • 12.4.3 Alzheimer’s Therapeutic Introduction
      • 12.4.4 Acadia Pharmaceuticals Revenue in Alzheimer’s Therapeutic Business (2014-2019)
      • 12.4.5 Acadia Pharmaceuticals Recent Development
    • 12.5 Biotie Therapies
      • 12.5.1 Biotie Therapies Company Details
      • 12.5.2 Company Description and Business Overview
      • 12.5.3 Alzheimer’s Therapeutic Introduction
      • 12.5.4 Biotie Therapies Revenue in Alzheimer’s Therapeutic Business (2014-2019)
      • 12.5.5 Biotie Therapies Recent Development
    • 12.6 Astra Zeneca
      • 12.6.1 Astra Zeneca Company Details
      • 12.6.2 Company Description and Business Overview
      • 12.6.3 Alzheimer’s Therapeutic Introduction
      • 12.6.4 Astra Zeneca Revenue in Alzheimer’s Therapeutic Business (2014-2019)
      • 12.6.5 Astra Zeneca Recent Development
    • 12.7 Eli Lilly
      • 12.7.1 Eli Lilly Company Details
      • 12.7.2 Company Description and Business Overview
      • 12.7.3 Alzheimer’s Therapeutic Introduction
      • 12.7.4 Eli Lilly Revenue in Alzheimer’s Therapeutic Business (2014-2019)
      • 12.7.5 Eli Lilly Recent Development
    • 12.8 Roche
      • 12.8.1 Roche Company Details
      • 12.8.2 Company Description and Business Overview
      • 12.8.3 Alzheimer’s Therapeutic Introduction
      • 12.8.4 Roche Revenue in Alzheimer’s Therapeutic Business (2014-2019)
      • 12.8.5 Roche Recent Development
    • 12.9 Merck
      • 12.9.1 Merck Company Details
      • 12.9.2 Company Description and Business Overview
      • 12.9.3 Alzheimer’s Therapeutic Introduction
      • 12.9.4 Merck Revenue in Alzheimer’s Therapeutic Business (2014-2019)
      • 12.9.5 Merck Recent Development
    • 12.10 H. Lundbeck
      • 12.10.1 H. Lundbeck Company Details
      • 12.10.2 Company Description and Business Overview
      • 12.10.3 Alzheimer’s Therapeutic Introduction
      • 12.10.4 H. Lundbeck Revenue in Alzheimer’s Therapeutic Business (2014-2019)
      • 12.10.5 H. Lundbeck Recent Development
    • 12.11 Takeda Pharmaceutical Company

    13 Market Forecast 2019-2025

    • 13.1 Market Size Forecast by Regions
    • 13.2 United States
    • 13.3 Europe
    • 13.4 China
    • 13.5 Japan
    • 13.6 Southeast Asia
    • 13.7 India
    • 13.8 Central & South America
    • 13.9 Market Size Forecast by Product (2019-2025)
    • 13.10 Market Size Forecast by Application (2019-2025)

    14 Analyst's Viewpoints/Conclusions

      15 Appendix

      • 15.1 Research Methodology
        • 15.1.1 Methodology/Research Approach
          • 15.1.1.1 Research Programs/Design
          • 15.1.1.2 Market Size Estimation
          • 12.1.1.3 Market Breakdown and Data Triangulation
        • 15.1.2 Data Source
          • 15.1.2.1 Secondary Sources
          • 15.1.2.2 Primary Sources
      • 15.2 Disclaimer

      In 2018, the global Alzheimer’s Therapeutic market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

      This report focuses on the global Alzheimer’s Therapeutic status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Alzheimer’s Therapeutic development in United States, Europe and China.

      The key players covered in this study
      Pfizer
      Novartis
      Axovant Sciences
      Acadia Pharmaceuticals
      Biotie Therapies
      Astra Zeneca
      Eli Lilly
      Roche
      Merck
      H. Lundbeck
      Takeda Pharmaceutical Company

      Market segment by Type, the product can be split into
      Memantine Hydrochloride
      Donepezil Hydrochloride
      Rivastigmine
      Galantamine Hydrobromide

      Market segment by Application, split into
      Hospitals
      Clinic
      Other

      Market segment by Regions/Countries, this report covers
      United States
      Europe
      China
      Japan
      Southeast Asia
      India
      Central & South America

      The study objectives of this report are:
      To analyze global Alzheimer’s Therapeutic status, future forecast, growth opportunity, key market and key players.
      To present the Alzheimer’s Therapeutic development in United States, Europe and China.
      To strategically profile the key players and comprehensively analyze their development plan and strategies.
      To define, describe and forecast the market by product type, market and key regions.

      In this study, the years considered to estimate the market size of Alzheimer’s Therapeutic are as follows:
      History Year: 2014-2018
      Base Year: 2018
      Estimated Year: 2019
      Forecast Year 2019 to 2025
      For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

      Buy now